XLO Xilio Therapeutics, Inc.
$8.93▼ -0.72%
Healthcare
Other
After hours
$8.68▼ -2.80%
Sep 11, 5:52 PM ET
Volume 4.8K
Avg Volume (10D) 10.8K
Key Metrics & Fundamentals
Market Cap
$58.76M
P/E Ratio
–
Div Yield
–%
52W Range
6.47 - 12.74
% vs 50 MA
-1.42%
% vs 200 MA
3.09%
RSI-14
45.3
MACD Histogram
-0.0200
Beta (1Y vs SPY)
0.94
Free Cash Flow
-$18.78M
Gross Rev
$18.69M
Gross Profit
$18.69M
EBITDA
$780,000
COGS
–
Operating Exp
$22.18M
Operating Income
-$3.49M
EBIT
-$3.49M
Pretax Income
-$6.37M
Net Income
-$6.37M
EPS (Diluted)
-0.33
Price & Volume History
Loading chart…
Recent News
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 2, 2026 8:30 PM
Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates
GlobeNewswire · Aug 12, 2026 11:30 AM
3 Small-Cap Biotech Stocks Pairing Rapid Revenue Growth With High Insider Ownership
Simply Wall St. · Jul 24, 2026 5:56 AM
Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer
GlobeNewswire · Jun 29, 2026 11:30 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See XLO's money flow as a full page
Social Sentiment
No Reddit posts found for XLO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.